HRP 283 - Research in Progress Seminar (RIP)
We hope you find this series of research talks by faculty and students in, or affiliated with, HRP, CHP and PCOR interesting.
If you have questions pleaes feel free to contact:
Corinna Haberland, MD, MS
T139, Redwood Bldg.
Dept. of Health Research and Policy
Stanford, CA 94305
(650) 498-5232 or email@example.com
***ONLY FOR THOSE TAKING THE COURSE FOR CREDIT***
Please be sure to sign in (on the sign-in sheet) at every session you attend.
In order to receive credit (one unit) for the quarter you must attend the talks – a maximum of two (2) absences is allowed.
CHP/PCOR Conference Room
117 Encina Commons
Wednesdays, 4:00 - 5:00 pm
|Date||Speaker||Title of Talk|
Jeremy Goldhaber-Fiebert, PhD
Assistant Professor of Medicine (PCOR) and, by courtesy, of Health Research and Policy
|Do you need to be crazy to exericse?
Reception to follow.
Mark Hlatky, MD
Professor of Health Research and Policy and of Medicine (Cardiovascular Medicine)
|Are Drug Eluting Stents for Multivessel Coronary Disease as Good as CABG?
Margaret Brandeau, PhD
Dept of Management Science and Engineering, Stanford
|Allocating Disease Control Funds: Modeling HIV Out of Isolation
Doug Owens, MD, MS
Professor of Medicine and of Health Research and Policy
Director, Center for Health Policy and Center for Primary Care and Outcomes Research
|Screening for Lung Cancer in the US: How the US Preventive Services Task Force Developed the New Lung Cancer Screening Guideline
Professor of Public Policy and of Law
University of California, Berkeley
|Special Seminar - Jointly hosted by FSI and CHP/PCOR
State Marijunana Legalization: A Guide for Agnostic Voters and Policymakers (Abstract)
*Please note: All research in progress seminars are off-the-record. Any information about
methodology and/or results are embargoed until publication.
Information about RIP and CHP/PCOR can also be found at healthpolicy.stanford.edu/events